Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma 14Lymphoma, Non-Hodgkin 10Lymphoma, Follicular 8Lymphoma, B-Cell 8Lymphoma, Mantle-Cell 7Burkitt Lymphoma 7Rhabdomyosarcoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Recurrence 5Leukemia 5Immunoblastic Lymphadenopathy 5Lymphoma, T-Cell, Peripheral 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Sarcoma, Ewing 3Lymphoma, Primary Effusion 3Sarcoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Osteosarcoma 2Neuroblastoma 2Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Hodgkin Disease 2Enteropathy-Associated T-Cell Lymphoma 2

Interventions

Cyclophosphamide 2ruxolitinib 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1brincidofovir 1Vincristine 1Raltegravir Potassium 1Prednisone 1Etoposide 1Doxorubicin 1Daclizumab 1Bortezomib 1B3(Fv)-PE38KDEL recombinant immunotoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia-Lymphoma, Adult T-Cell × Vincristine × Clear all
NCT01000285 2017-03-28

ATLL

Washington University School of Medicine

Phase 1/2 Completed
18 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡